Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae
- PMID: 10594558
- PMCID: PMC1905437
- DOI: 10.1046/j.1365-2249.1999.01077.x
Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae
Abstract
The contribution of serotype-specific IgG concentration, subclasses, and avidity to opsonophagocytic activity (OPA) against Streptococcus pneumoniae (Pnc) was evaluated in sera of adults and infants immunized with different pneumococcal vaccines. Antibody concentrations and avidities were measured by enzyme immunoassay (EIA) and OPAs by killing assay of Pnc. The most important factor contributing positively to OPA was the specific IgG level. In infants, a tendency to negative correlation was found between the concentration needed for killing of bacteria and avidity, suggesting that less antibodies of high rather than low avidity were required for killing. No such correlation was seen in adults. However, in adults the avidity was high already before vaccination and the variation was narrow. Thus, avidity was probably not a limiting factor influencing OPA. The effect of IgG2/IgG1 ratio on OPA was mostly negative but insignificant.
Figures


Similar articles
-
Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.Clin Diagn Lab Immunol. 2002 Sep;9(5):1032-8. doi: 10.1128/cdli.9.5.1032-1038.2002. Clin Diagn Lab Immunol. 2002. PMID: 12204955 Free PMC article.
-
Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.J Infect Dis. 1997 Sep;176(3):698-703. doi: 10.1086/514093. J Infect Dis. 1997. PMID: 9291318
-
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.J Infect Dis. 2001 Nov 1;184(9):1211-5. doi: 10.1086/323648. Epub 2001 Sep 25. J Infect Dis. 2001. PMID: 11598848 Clinical Trial.
-
Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.Clin Vaccine Immunol. 2012 Oct;19(10):1618-23. doi: 10.1128/CVI.00248-12. Epub 2012 Aug 8. Clin Vaccine Immunol. 2012. PMID: 22875604 Free PMC article.
-
Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.Clin Diagn Lab Immunol. 2005 Jan;12(1):19-27. doi: 10.1128/CDLI.12.1.19-27.2005. Clin Diagn Lab Immunol. 2005. PMID: 15642980 Free PMC article. Review. No abstract available.
Cited by
-
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.Vaccine. 2011 Jan 10;29(3):535-44. doi: 10.1016/j.vaccine.2010.10.046. Epub 2010 Oct 31. Vaccine. 2011. PMID: 21044669 Free PMC article. Clinical Trial.
-
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.Vaccine. 2011 Jun 15;29(27):4499-506. doi: 10.1016/j.vaccine.2011.04.038. Epub 2011 May 1. Vaccine. 2011. PMID: 21539882 Free PMC article. Clinical Trial.
-
Diversity in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Study of Women From Bangladesh, Malawi, and the United Kingdom.J Infect Dis. 2025 Feb 20;231(2):e456-e467. doi: 10.1093/infdis/jiae607. J Infect Dis. 2025. PMID: 39692506 Free PMC article.
-
Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?Clin Diagn Lab Immunol. 2000 May;7(3):468-76. doi: 10.1128/CDLI.7.3.468-476.2000. Clin Diagn Lab Immunol. 2000. PMID: 10799463 Free PMC article.
-
Mouse IgG2a Antibodies Specific for the Commensal Streptococcus mitis Show Stronger Cross-Reactivity with Streptococcus pneumoniae than IgG1 Antibodies.J Immunol Res. 2019 Sep 10;2019:7906724. doi: 10.1155/2019/7906724. eCollection 2019. J Immunol Res. 2019. PMID: 31583259 Free PMC article.
References
-
- Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Johnson C, Madore D, Hogerman D. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr Infect Dis J. 1994;13:368–72. - PubMed
-
- Käyhty H, Åhman H, Rönnberg P-R, Tillikainen R, Eskola J. Pneumococcal polysaccharide–meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis. 1995;172:1273–8. - PubMed
-
- Leach A, Ceesay SJ, Banya WA, Greenwood BM. Pilot trial of pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants. Pediatr Infect Dis J. 1996;15:333–9. - PubMed
-
- Dagan R, Melamed R, Zamir O, Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr Infect Dis J. 1997;16:1053–9. - PubMed
-
- Åhman H, Käyhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J. Streptococcus pneumoniae capsular polysaccharide–diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J. 1998;17:211–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources